The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Research-Grade Proteins Global Market Report 2024, the research-grade proteins market is expected to show significant growth in the forecast period.

The research-grade proteins market has experienced significant growth and is expected to continue on this upward trajectory in the coming years. This blog explores the current market landscape, key drivers of growth, and major players in the field.

Market Overview

• Current Market Size: The research-grade proteins market was valued at $0.91 billion in 2023.
• Growth Forecast: It is anticipated to grow to $1.11 billion by 2024, reflecting a compound annual growth rate (CAGR) of 21.1%.
• Long-Term Outlook: By 2028, the market is projected to reach $2.4 billion, with a CAGR of 21.3%.

Drivers of Growth

• Increasing Research Activities: There is a growing emphasis on research across pharmaceutical and biotechnology sectors.
• Rising Demand for Personalized Medicine: Tailoring treatments to individual genetic profiles boosts the need for specialized research-grade proteins.
• Government and Academic Investments: Increased funding and strategic collaborations support market expansion.
• Technological Advancements: Innovations in proteomics and data analytics are driving demand for advanced research tools.

View More On The Research-Grade Proteins Market Report 2024 – https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

Impact of Clinical Trials

• Rising Number of Trials: Clinical trials are on the rise, with 477,234 registered globally by the end of 2023.
• Role of Research-Grade Proteins: These proteins are crucial for biomarker development, assay development, drug target identification, and quality control, ensuring reliable experimental outcomes.

Major Companies in the Market

• Key Players:Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, and GenScript Biotech Corporation are leading the market.
• Recent Developments:
  • Thermo Fisher Scientific Inc.: Acquired PeproTech in January 2022 for $1.85 billion, enhancing its research-grade protein portfolio.

Cas9 Protein Development

• Advancements in Genome Editing: Cas9 proteins act as molecular scissors for precise DNA editing. Thermo Fisher’s introduction of the GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022 highlights innovation in this area.
• Applications: These developments facilitate advancements in genetic engineering and therapeutic research.

Market Segmentation

• By Product:Includes cytokines and growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, and other products.
• By Host Cell:Segmented into mammalian cells, bacterial cells, fungi and yeast, insect cells, and other host cells.
• By End-Use:Covers pharmaceutical and biotechnology companies, academic and research institutes, and other end-users.

Regional Insights

• North America: The largest market for research-grade proteins in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period, driven by increasing research activities and investments in biotechnology.

Conclusion

The research-grade proteins market is on a robust growth trajectory, fueled by advancements in research, rising demand for personalized medicine, and significant investments in the sector. With key players innovating and expanding their portfolios, the market is set to witness continued expansion and evolving opportunities in the years to come.

Request A Sample Of The Global Research-Grade Proteins Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15917&type=smp